Item no. |
TRC-F727800-50mg |
Manufacturer |
Toronto Research Chemicals
|
CASRN |
88889-14-9 |
Amount |
50 mg |
Quantity options |
100 mg
10 mg
25 mg
50 mg
5 mg
|
Category |
|
Type |
Biochemicals |
Specific against |
other |
Purity |
98% |
InCHI |
1S/C30H46NO7P.Na/c1-4-28(33)37-30(22(2)3)38-39(36,18-12-11-15-23-13-7-5-8-14-23)21-27(32)31-20-25(19-26(31)29(34)35)24-16-9-6-10-17-24;/h5,7-8,13-14,22,24-26,30H,4,6,9-12,15-21H2,1-3H3,(H,34,35);/q;+1/p-1/t25-,26+,30-,39-;/m1./s1 |
Smiles |
O=[P@@](CC(N1[C@@H](C(O[Na])=O)C[C@H](C2CCCCC2)C1)=O)(O[C@@H](C(C)C)OC(CC)=O)CCCCC3=CC=CC=C3 |
ECLASS 10.1 |
32160490 |
ECLASS 11.0 |
32160490 |
UNSPSC |
12000000 |
Alias |
(4S)-4-Cyclohexyl-1-[[(R)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]acetyl]-L-proline, sodium salt; [1[S*(R*)],2alpha,4beta]-4-Cyclohexyl-1-[[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]acetyl]-L-proline, sodium salt; Acecor; Eosinopril; Fosinopril sodium; Monopril; SQ 28555; Secorvas; Staril |
Available |
|
Mol. Weight |
585, 64 |
Country of Origin |
Canada |
IUPAC |
sodium; (2S, 4S)-4-cyclohexyl-1-[2-[[(1R)-2-methyl-1-propanoyloxypropoxy]-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate |
Storage Condition |
-20 |
Shipping Condition |
RT |
Shipping Info |
Not a Dangerous good |
Manufacturers Category |
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites; |
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.